ACVR1 and ovarian cancer: However, ALK2 has been shown to be a relevant type I receptor for BMP9 in various non-endothelial cells such as ovarian cancer cells, multiple myeloma cells, mesenchymal stem cells and myoblasts8,19,20,33.